cGAMP-Adjuvanted Multivalent Influenza mRNA Vaccines Induce Broadly Protective Immunity through Cutaneous Vaccination in Mice

Researchers fabricated a multivalent influenza mRNA lipid nanoparticle vaccine with mRNAs of Hemagglutinins from influenza H1N1 and H3N2 viruses, Matrix protein 1, and Nucleoprotein.